ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals Revenue

In the year 2025, ANI Pharmaceuticals had annual revenue of $883.37M with 43.78% growth. ANI Pharmaceuticals had revenue of $247.06M in the quarter ending December 31, 2025, with 29.64% growth.

• Revenue (ttm): $883.37M
• Revenue Growth: +43.78%
• P/S Ratio: 2.12
• Revenue / Employee: $910,687
• Employees: 970
• Market Cap: 1.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	883.37M	268.99M	43.78%
Dec 31, 2024	614.38M	127.56M	26.20%
Dec 31, 2023	486.82M	170.43M	53.87%
Dec 31, 2022	316.39M	100.25M	46.38%
Dec 31, 2021	216.14M	7.66M	3.67%
Dec 31, 2020	208.48M	1.93M	0.93%
Dec 31, 2019	206.55M	4.97M	2.47%
Dec 31, 2018	201.58M	24.73M	13.99%
Dec 31, 2017	176.84M	48.22M	37.49%
Dec 31, 2016	128.62M	52.30M	68.53%
Dec 31, 2015	76.32M	20.35M	36.36%
Dec 31, 2014	55.97M	25.89M	86.06%
Dec 31, 2013	30.08M	9.71M	47.67%
Dec 31, 2012	20.37M	19.94M	4,581.27%
Dec 31, 2011	435.16K	-2.04M	-82.41%
Dec 31, 2010	2.47M	1.22M	96.67%
Dec 31, 2009	1.26M	-2.52M	-66.73%
Dec 31, 2008	3.78M	3.29M	666.82%
Dec 31, 2007	493.05K	-13.95M	-96.59%
Dec 31, 2006	14.44M	14.18M	5,488.75%
Dec 31, 2005	258.35K	-	-

Data Source: Fiscal.ai Last updated: Feb 27, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error